First Mercantile Trust’s Aratana Therapeutics, Inc. PETX Stock Holding History

First Mercantile Trust’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-15,300	Closed	-$129K	–	1000
2015 Q3	$129K	Sell	15,300 -5,100	-25%	-$86.3K	0.01%	767
2015 Q2	$308K	Sell	20,400 -100	-0.5%	-$1.44K	0.03%	626
2015 Q1	$328K	Buy	20,500 +10,300	+101%	+$183K	0.03%	609
2014 Q4	$182K	Buy	+10,200	New	+$127K	0.02%	696

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

First Mercantile Trust's PETX Position: Q4 2015 in Review

First Mercantile Trust sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2015, closing a stake of 15,300 shares — an estimated $129K sold.

First Mercantile Trust first reported a position in PETX in Q4 2014 and held it in 4 quarters. The position peaked at $328K in Q1 2015. 98 funds tracked by Wall St. Rank hold PETX as of Q4 2015.

First Mercantile Trust reported no remaining Aratana Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
First Mercantile Trust sold 15,300 Aratana Therapeutics, Inc. shares in Q4 2015, an estimated $129K.
First Mercantile Trust first reported a position in Aratana Therapeutics, Inc. in Q4 2014 and held it in 4 quarters.
First Mercantile Trust's Aratana Therapeutics, Inc. position peaked at $328K in Q1 2015.
98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2015.

Based on First Mercantile Trust's 13F filing for Q4 2015, filed 1 Feb 2016.